Jens Bentzen
Overview
Explore the profile of Jens Bentzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
552
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watt T, Christoffersen T, Brogaard M, Bjorner J, Bentzen J, Hahn C, et al.
Best Pract Res Clin Endocrinol Metab
. 2023 Feb;
37(1):101732.
PMID: 36732089
To explore the impact of differentiated thyroid cancer (DTC) on quality of life (QoL) a clinical analytical framework was developed. Based on the clinical analytical framework, a systematic literature search...
2.
Soby S, Gothelf A, Gyldenkerne N, Bentzen J, Nowicka-Matus K, Tramm T, et al.
Acta Oncol
. 2022 Aug;
61(8):972-978.
PMID: 35913523
Introduction: The aim of this study was to investigate phase IV efficacy, of the PD-1 inhibitor nivolumab among an unselected and unbiased national cohort of recurrent/metastatic Head and Neck Squamous...
3.
Gronlund M, Jakobsen K, Mirian C, Gronhoj C, Nielsen K, Charabi B, et al.
Oral Oncol
. 2021 Oct;
122:105583.
PMID: 34695757
Objectives: Nasopharyngeal malignancies are reported having decreasing incidence and reduced mortality. This study provides a nationwide update of the incidence and survival in Denmark. Materials And Methods: The Danish Cancer...
4.
Waersted S, Andersen E, Bentzen J
Acta Otolaryngol
. 2021 May;
141(6):649-655.
PMID: 34028322
Background: Treatment of squamous cell carcinoma of the supraglottic larynx (SCCSL) in Denmark has changed in several ways from the year 2000 to 2014, including the introduction of IMRT radiation...
5.
Gram S, Rasmussen J, Feldt-Rasmussen U, Bentzen J, Lelkaitis G, von Buchwald C, et al.
Eur Thyroid J
. 2019 Nov;
8(5):246-255.
PMID: 31768335
Objectives: The aims of this study were to report the risk of thyroid malignancy in cases of either benign fine-needle aspiration (FNA) or without FNA performed, and to investigate possible...
6.
Sakso M, Andersen E, Bentzen J, Andersen M, Johansen J, Primdahl H, et al.
Acta Oncol
. 2019 Sep;
58(10):1495-1501.
PMID: 31519130
The study aimed to evaluate Hyperfractionated, Accelerated Radiotherapy (HART) with nimorazole for patients with head and neck squamous cell carcinoma (HNSCC) using loco-regional failure (LRF), overall survival (OS), early and...
7.
Reinke R, Mathiesen J, Larsen S, Hahn C, Pedersen H, Bentzen J, et al.
Cancer Epidemiol
. 2019 Mar;
60:46-50.
PMID: 30909152
Background: Incidental and non-incidental papillary microcarcinomas (PMC) are associated with different outcomes and treatment options may vary. The least favourable outcome is typically seen when carcinoma is suspected prior to...
8.
The Nephroprotective Effect of Mannitol in Head and Neck Cancer Patients Receiving Cisplatin Therapy
Hagerstrom E, Lindberg L, Bentzen J, Brodbaek K, Zerahn B, Kristensen B
Clin Med Insights Oncol
. 2019 Jan;
13:1179554918821320.
PMID: 30670924
Introduction: Cisplatin is used as treatment for several different malignancies and a well-known complication is irreversible kidney damage. To protect the kidneys, this treatment is often combined with mannitol infusion...
9.
Mathiesen J, Kroustrup J, Vestergaard P, Stochholm K, Poulsen P, Rasmussen A, et al.
Clin Epidemiol
. 2019 Jan;
11:93-99.
PMID: 30666164
Background: The completeness of arranged during ransfection () testing in patients with medullary thyroid carcinoma (MTC) was recently reported as 60%. However, the completeness on a population level is unknown....
10.
Mathiesen J, Kroustrup J, Vestergaard P, Stochholm K, Poulsen P, Rasmussen A, et al.
Thyroid
. 2019 Jan;
29(3):368-377.
PMID: 30618340
Background: Survival of medullary thyroid carcinoma (MTC) subgroups in relation to the general population is poorly described. Data on the factors predicting long-term biochemical cure in MTC patients are nonexistent...